| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64 |
| filingDate |
2002-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b660b7bbeb30eb457326cffbfeeb1bb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09ae0c650768622238d5d135715bb48a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52f315ebb288e261e191700631302eb2 |
| publicationDate |
2004-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004097567-A1 |
| titleOfInvention |
Pharmaceutical composition |
| abstract |
The invention relates to a pharmaceutical compositions for the treatment of diabetes comprising, as active principles, a derivation of the 5-phenoxyalkyl-2,4-thiazolidinedione type and a compound that stimulates insulin secretion. |
| priorityDate |
2001-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |